NOVEL MUTATION IN THE APOB GENE (Apo B-15.56):
A CASE REPORT
Bove M1, Carnevali L, Cicero AFG, Tarugi P, Gaddi AV
*Corresponding Author: Marilisa Bove, “GC. Descovich” Atherosclerosis and Metabolic Disease
Research Unit, Internal Medicine, Aging & Kidney Diseases Department, University of Bologna,
Policlinico S.Orsola, Malpighi, Via Massarenti 9, 40138 Bologna, Italy; Tel./FAX: +39-(0)516-363-262;
E-mail: marilisa.bove@aosp.bo.it
page: 65
|
|
REFERENCES
1. Linton MF, Farese RV Jr, Young SG. Familial
hypobetalipoproteinemia. J Lipid Res. 1993; 34(4):
521-541.
2. Tarugi P, Averna M, Di Leo E, Cefalu AB,
Noto D, Magnolo L, Cattin L, Bertolini S, Calandra
S. (Author: all authors must be cited) Molecular
diagnosis of hypobetalipoproteinemia: an ENID
review. Atherosclerosis. 2007; 195(2): e19-27.
3. Burnett JR, Hooper AJ. Common and rare
gene variants affecting plasma LDL cholesterol.
Clin Biochem Rev. 2008; 29(1): 11-26.
4. Whitfield AJ, Barrett PH, van Bockxmeer
FM, Burnett JR. Lipid disorders and mutations in
the APOB gene. Clin Chem. 2004; 50(10): 1725-
1732.
5. Olofsson SO, Wiklund O, Boren J.
Apolipoproteins A-I and B: biosynthesis, role in
the development of atherosclerosis and targets for
intervention against cardiovascular disease. Vasc
Health Risk Manag. 2007; 3(4): 491-502.
6. Schonfeld G. Familial hypobetalipoproteinemia:
a review. J Lipid Res. 2003; 44(5): 878-883.
7. Schonfeld G, Lin X, Yue P. Familial
hypobetalipoproteinemia: genetics and metabolism.
Cell Mol Life Sci. 2005; 62(12): 1372-1378.
8. Elias N, Patterson BW, Schonfeld G.
Decreased production rates of VLDL triglycerides
and ApoB-100 in subjects heterozygous for familial
hypobetalipoproteinemia. Arterioscler Thromb
Vasc Biol. 1999; 19(11): 2714-2721.
9. Hooper AJ, van Bockxmeer FM, Burnett JR.
Monogenic hypocholesterolaemic lipid disorders
and apolipoprotein B metabolism. Crit Rev Clin
Lab Sci. 2005; 42(5-6): 515-545.
10. Amaro A, Fabbrini E, Kars M, Yue P,
Schechtman K, Schonfeld G, Klein S. (Author:
all authors must be cited) Dissociation between
intrahepatic triglyceride content and insulin
resistance in familial hypobetalipoproteinemia.
Gastroenterology. 2010; [Epub ahead of print].
11. Sankatsing R, Fouchier S, de Haan S, Hutten
B, de Groot E, Kastelein J, Stroes ES. Hepatic
and cardiovascular consequences of familial
hypobetalipoproteinemia. Arterioscler Thromb
Vasc Biol. 2005; 25(9): 1979-1984.
12. Cohen J, Boerwinkle E, Mosley TJ, Hobbs
H. Sequence variations in PCSK9, low LDL, and
protection against coronary heart disease. N Engl J
Med. 2006; 354(12): 1264-1272.
13. Sambrook J, Fritsch EF, Maniatis T.
Molecular Cloning. A Laboratory Manual. Cold
Spring Arbor: Cold Spring Laboratory; 1989.
14. Knott T, Wallis S, Powell L, Pease R, Lusis
A, Blackhart B, McCarthy BJ, Mahley RW, Levy-
Wilson B, Scott J. Complete cDNA and derived
protein sequence of human apolipoprotein B-100.
Nucleic Acids Res. 1986; 14(18): 7501-7503.
15. Tarugi P, Lonardo A, Ballarini G, Erspamer
L, Tondelli E, Bertolini S, Calandra S. A study of
fatty liver disease and plasma lipoproteins in a kindred with familial hypobetalipoproteinemia due
to a novel truncated form of apolipoprotein B (APO
B-54.5). J Hepatol. 2000; 33(3): 361-370.
16. Tanoli T, Yue P, Yablonskiy D, Schonfeld
G. Fatty liver in familial hypobetalipoproteinemia:
roles of the APOB defects, intra-abdominal adipose
tissue, and insulin sensitivity. J Lipid Res. 2004;
45(5): 941-947.
17. Grundy SM. Metabolic syndrome: connecting
and reconciling cardiovascular and diabetes worlds. J
Am Coll Cardiol. 2006; 47(6): 1093-1100.
18. Alberti KG, Zimmet P, Shaw J. The
metabolic syndrome — a new worldwide definition.
Lancet. 2005; 366(9491): 1059-1062.
19. Executive Summary of The Third Report
of The National Cholesterol Education Program
(NCEP) Expert Panel on Detection, Evaluation,
And Treatment of High Blood Cholesterol In Adults
(Adult Treatment Panel III). JAMA. 2001; 285(19):
2486-2497.
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
